Friday, November 29, 2024 10:01:46 AM
dennisdave,
Nope, just want to see MHRA get er done. Some treatments are more important than others to consider getting to patients sooner and DCVax-L is one of them. They SHOULD get special attention. We are talking about 100s to thousands of patients that would have had an actual chance for essentially a cure that are not getting that chance. I also don’t want investors to get crushed by any false hopes due to reasonable predictions that might still fail to be realized which the shorts can use as opportunities to jump all over. We have had plenty of that in the past and even recently. The problem is we just don’t have good enough information to know for sure when a decision will occur which is why guesses keep changing but have historically been significantly later than most if not all longs have expected. Best wishes.
Nope, just want to see MHRA get er done. Some treatments are more important than others to consider getting to patients sooner and DCVax-L is one of them. They SHOULD get special attention. We are talking about 100s to thousands of patients that would have had an actual chance for essentially a cure that are not getting that chance. I also don’t want investors to get crushed by any false hopes due to reasonable predictions that might still fail to be realized which the shorts can use as opportunities to jump all over. We have had plenty of that in the past and even recently. The problem is we just don’t have good enough information to know for sure when a decision will occur which is why guesses keep changing but have historically been significantly later than most if not all longs have expected. Best wishes.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
